Standardization of amniotic fluid leptin levels and utility in maternal overweight and fetal undergrowth

J Perinatol. 2015 Aug;35(8):547-52. doi: 10.1038/jp.2015.39. Epub 2015 Apr 30.

Abstract

Objective: Leptin is an adipokine that regulates energy homeostasis. The objective of this study was to establish a gestational age-specific standard for amniotic fluid leptin (AFL) levels and examine the relationship between AFL, maternal overweight and fetal growth restriction.

Study design: Amniotic fluid was obtained at mid-gestation from singleton gravidas, and leptin was quantified using enzyme-linked immunosorbent assay. Amniotic fluid samples from 321 term pregnancies were analyzed. Clinical data, including fetal ultrasound measurements and maternal and infant characteristics, were available for a subset of patients (n=45).

Results: The median interquartile range AFL level was significantly higher at 14 weeks' gestation (2133 pg ml(-1) (1703 to 4347)) than after 33 weeks' gestation (519 pg ml(-1) (380 to 761), P trend<0.0001), an average difference of 102 pg ml(-1) per week. AFL levels were positively correlated with maternal pre-pregnancy body mass index (BMI) (r=0.36, P=0.03) adjusting for gestational age at measurement, but were not associated with fetal growth.

Conclusions: AFL levels are higher at mid-gestation than at late gestation, and are associated with maternal pre-pregnancy BMI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amniotic Fluid / metabolism*
  • Birth Weight
  • Body Mass Index
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fetal Development
  • Fetal Growth Retardation / metabolism*
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Leptin / analysis*
  • Leptin / standards*
  • Linear Models
  • Male
  • Overweight / metabolism*
  • Placenta / pathology
  • Pregnancy
  • Pregnancy Trimester, Second
  • Pregnancy Trimester, Third

Substances

  • Leptin